Sorry, you need to enable JavaScript to visit this website.

accepting new patients

Willis Knighton Physician Network

Locations

Willis Knighton Hematology/Oncology

2600 Kings Highway
Suite 300
Shreveport , LA 71103

View hours
Monday
8:00am - 5:00pm
Tuesday
8:00am - 5:00pm
Wednesday
8:00am - 5:00pm
Thursday
8:00am - 5:00pm
Friday
8:00am - 5:00pm
Willis Knighton Hematology/Oncology

Willis Knighton Hematology/Oncology Pierremont

8001 Youree Drive
Suite 500
Shreveport , LA 71115

View hours
Monday
8:00am - 5:00pm
Tuesday
8:00am - 5:00pm
Wednesday
8:00am - 5:00pm
Thursday
8:00am - 5:00pm
Friday
8:00am - 5:00pm
Willis Knighton Hematology/Oncology Pierremont

About Me

Anil Veluvolu, MD, specializes in the treatment of hepatobiliary and upper gastrointestinal tumors, which includes the liver, gallbladder, bile ducts, pancreas, esophagus, stomach and first part of the small intestine. He appreciates the bravery, courage and mental strength of all patients he sees at Hematology/Oncology Associates-Pierremont. He works to involve patients and their loved ones in treatment decisions, as Dr. Veluvolu prioritizes the patient’s quality of life along with their increased quantity of life. 

Educated in Shreveport, Dr. Veluvolu graduated college from LSUS then went on to medical school at LSU Health Sciences Center-Shreveport. His internship, internal medicine residency and hematology/oncology fellowship were completed on the same campus. He is certified by the American Board of Internal Medicine. 

Education

Fellowship:
LSUHSC Shreveport School of Medicine

Residency:
LSUHSC Shreveport School of Medicine

Internship:
LSUHSC Shreveport School of Medicine

Medical School:
LSUHSC Shreveport School of Medicine , MD

Insurances Accepted

  • AARP Medicare Supplemental Plans
  • Aetna
  • Aetna Better Health of Louisiana
  • Aetna Coventry Advantra Louisiana
  • Aetna Coventry Medicare Dual Preferred
  • Aetna Medicare Freedom PPO
  • Amerihealth Caritas Louisiana
  • Beech Street (Multiplan)
  • Blue Cross/Blue Shield - PPO Preferred Care
  • Blue Cross/Blue Shield Federal Employees
  • Blue Cross/Blue Shield of Louisiana - HMO Louisiana
  • Blue Cross/Blue Shield of Louisiana - Medicare Advantage
  • Blue Cross/Blue Shield OGB
  • Cigna HealthCare
  • Coventry Health Care (Aetna)
  • First Health
  • GEHA (Government Employees Health Association)
  • Gilsbar
  • Health Plus of Louisiana
  • Healthy Blue
  • Humana
  • Humana Choice PPO
  • Humana Gold Plus SNP Dual Eligible
  • IMA of Louisiana
  • Louisiana Healthcare Connections
  • Louisiana Medicaid
  • Louisiana Medicaid CHIP
  • Mail Handler's Benefit Plan (Aetna)
  • Medicare Railroad
  • Medicare Traditional Part B
  • Multiplan
  • Mutual of Omaha Supplemental Plans
  • Novasys Health
  • People's Health
  • PHCS (Private Healthcare Systems / Multiplan)
  • PPO Plus
  • Tricare for Life
  • Tricare Prime
  • Tricare Select / Standard
  • UMR (United Healthcare)
  • United Healthcare
  • United Healthcare Community Plan - Medicaid
  • United Healthcare Dual Complete
  • Vantage Health Plans – Commercial & Medicare Advantage
  • Workers Compensation
Show more

Conditions Treated

  • Acute Leukemia
  • Acute Lymphoid Leukemia
  • Acute Myeloid Leukemia
  • Adrenal Gland Cancer
  • Anal and Rectal Cancer
  • Anemia
  • Antiphospholipid Syndrome (APS)
  • Aortic Embolism and Thrombosis
  • Basal Cell Carcinoma
  • Bile Duct Cancer
  • Bladder Cancer
  • Bleeding Disorders
  • Blood Disorders in Pregnancy
  • Bone Cancer
  • Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Breast Cancer
  • Central Nervous System Lymphoma
  • Cervical Cancer
  • Chordoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Coagulation Disorders (incl. Hemophilia)
  • Colorectal Cancer
  • Deep Vein Thrombosis (DVT)
  • Ductal Carcinoma in Situ
  • ENT Cancer
  • Esophageal Cancer
  • Eye Cancer
  • Gallbladder and Biliary Tract Cancer
  • Gallbladder Cancer
  • Gynecologic Cancer
  • Hemophilia
  • Hemophilia A
  • Hodgkin's Disease
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Kaposi's Sarcoma
  • Kidney Cancer
  • Lambert-Eaton Syndrome
  • Laryngeal Cancer
  • Leukocytosis
  • Liver Cancer
  • Lung Cancer
  • Lymphocytosis
  • Lymphoma, Large-Cell
  • Lymphosarcoma
  • Malignant Histiocytosis
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Maternal Anemia
  • Mediastinal Tumors, Malignant
  • Mediastinal Tumors, Not Specified as Malignant
  • Melanoma
  • Metastatic Breast Cancer
  • Multiple Endocrine Neoplasia
  • Mycosis Fungoides
  • Myelodysplastic Syndromes (MDS)
  • Myeloma
  • Myeloproliferative Disorders
  • Neuroendocrine Tumors
  • Neutropenia
  • Nodular Lymphoma
  • Non-Hodgkin Lymphoma
  • Oral Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pancytopenia
  • Peritoneal Cancer
  • Pleural Cancer
  • Polycythemia Rubra Vera
  • Primary Central Nervous System Lymphoma
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Prostate Cancer
  • Purpura
  • Reticulosarcoma
  • Secondary Hypertension
  • Secondary Malignancies
  • Skin Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Squamous Cell Carcinoma
  • Stomach (Gastric) Cancer
  • Stomach and Small Intestine Cancer
  • Thalassemia
  • Throat Cancer (Hypopharyngeal)
  • Throat Cancer (Nasopharyngeal)
  • Throat Cancer (Oropharyngeal)
  • Thrombocytosis
  • Thyroid Cancer
  • Tongue Cancer
  • Tonsil Cancer
  • Uterine Cancer
  • Venous Thromboembolism (VTE)
  • Vitamin B Deficiency
  • Vitamin B12 Deficiency
  • von Willebrand Disease
Show more

Procedures Performed

  • Anemia and Iron Deficiency Screening
  • Bone Marrow Evaluation
  • Erythropoietin Test
  • Leukemia Diagnostic Evaluations
  • Lymphoma Evaluation
  • Thoracentesis

Provider Ratings

4.9 out of 5

(516 ratings)

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.